Expertise in
5
conditions

Patrick Verschueren

Ku
Leuven, VLG, BE 
Expertise in
5
conditions
Ku
Leuven, VLG, BE 

Overview

Patrick Verschueren practices practicing medicine in Leuven, Belgium.

Mr. Verschueren is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Rheumatoid Lung Disease, and COVID-19.

He is actively involved in clinical research, co-authoring 166 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

KU
Leuven, VLG, Belgium
Other Locations
AZORG Flanders
Aalst, VLG, Belgium
Lueven, Belgium
Brussels, BRU, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Follow-up Phase 2a Open-label Study to Evaluate the Long-term Safety and Efficacy Profile of ABX464 in Patients With Moderate to Severe Active Rheumatoid Arthritis
A Follow-up Phase 2a Open-label Study to Evaluate the Long-term Safety and Efficacy Profile of ABX464 in Patients With Moderate to Severe Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: November 17, 2025
Intervention Type: Drug
Study Drug: ABX464
Study Phase: Phase 2
Phase IIa Randomized, Double Blind, Placebo Controlled, Multiple Dose Study on ABX464 in Combination With Methotrexate (MTX), in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have Inadequate Response to MTX or/and to Anti-Tnfα, or Intolerance to Anti-Tnfα
Phase IIa Randomized, Double Blind, Placebo Controlled, Multiple Dose Study on ABX464 in Combination With Methotrexate (MTX), in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have Inadequate Response to MTX or/and to Anti-Tnfα, or Intolerance to Anti-Tnfα
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Drug
Study Drugs: ABX464, Methotrexate
Study Phase: Phase 2
View 1 Less Clinical Trial

166 Total Publications

Reply.
Reply.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 20, 2026

Frequently Asked Questions about Patrick Verschueren

Is Patrick Verschueren a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Patrick Verschueren is classified as an Elite expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Patrick Verschueren participate in research or clinical trials?

Yes. Patrick Verschueren has published 166 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Patrick Verschueren's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Verschueren's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile